US FTC says in-house insulin pricing suit should continue
MLex Summary: The US Federal Trade Commission opposed Express Scripts and other pharmacy benefit managers’ request for preliminarily injunction against an administrative proceeding initiated by the FTC pending an appeal. “Plaintiffs’ lead...To view the full article, register now.
Already a subscriber? Click here to view full article